Alternatives to Ganciclovir If You Can't Fill Your Prescription

Ganciclovir is a critical antiviral — but it is not the only option for treating cytomegalovirus (CMV) infections or preventing CMV disease in transplant recipients. If you are having difficulty finding ganciclovir in stock, or if your doctor needs to adjust your treatment plan, there are several well-established alternatives depending on your specific medical situation.

This guide covers the most commonly used alternatives to ganciclovir for each of its main indications. Always consult your doctor or specialist before making any changes to your antiviral regimen — switching antivirals is a clinical decision that depends on your immune status, kidney function, and the specific type of CMV infection you have.

Alternative #1: Valganciclovir (Valcyte) — Best Oral Option

Valganciclovir (brand name Valcyte) is an oral prodrug that your body converts directly into ganciclovir after you swallow it. This means it works by the same mechanism — blocking the CMV DNA polymerase enzyme from replicating the virus — but it comes as a tablet you can take at home.

Valganciclovir is FDA-approved for both treatment of CMV retinitis in AIDS patients and prevention of CMV disease after kidney, heart, and kidney-pancreas transplants. For many patients who can absorb oral medications well, it achieves similar blood levels of active ganciclovir as the IV form.

Best for: Outpatient CMV treatment and prophylaxis when IV access is not required. Widely available as a generic at most retail pharmacies — far easier to obtain than IV ganciclovir.

Important: Valganciclovir carries the same serious side effects as ganciclovir, including blood count suppression and potential effects on fertility. Dose adjustments are required for kidney impairment.

Alternative #2: Foscarnet (Foscavir) — For Resistant CMV

Foscarnet (brand name Foscavir) is an IV antiviral that blocks CMV replication through a different mechanism than ganciclovir — it directly inhibits the viral DNA polymerase without requiring phosphorylation by the viral enzyme UL97. This makes it valuable when CMV develops resistance to ganciclovir (which occurs through mutations in the UL97 or UL54 genes).

Foscarnet has significant toxicity, particularly to the kidneys. It causes electrolyte abnormalities and can affect calcium and magnesium levels, requiring close monitoring during treatment. It is typically reserved for patients with ganciclovir-resistant CMV or who cannot tolerate ganciclovir's hematologic side effects.

Best for: Ganciclovir-resistant CMV infections; patients who can't tolerate ganciclovir's myelosuppression.

Alternative #3: Cidofovir — Second-Line IV Option

Cidofovir is another IV antiviral used for CMV retinitis in AIDS patients, particularly when ganciclovir or foscarnet cannot be used. It has the advantage of being dosed only once weekly (induction) or every other week (maintenance), but it carries substantial nephrotoxicity risk and requires prehydration with IV fluids and probenecid co-administration to protect the kidneys.

Best for: Patients with ganciclovir and foscarnet intolerance or resistance; less frequent IV dosing can be convenient for maintenance therapy.

Alternative #4: Letermovir (Prevymis) — For Transplant Prophylaxis

Letermovir (Prevymis) is a newer antiviral approved specifically for CMV prophylaxis in adults who have received an allogeneic hematopoietic stem cell transplant (bone marrow transplant). It works by a completely different mechanism — inhibiting the CMV terminase complex (a viral enzyme not found in human cells), which means it does not cause the bone marrow suppression that ganciclovir does.

Letermovir is available in both IV and oral forms and is generally well tolerated. It is not currently approved for CMV treatment (only prevention), and it is not indicated for solid organ transplant CMV prophylaxis.

Best for: Stem cell transplant recipients who need CMV prophylaxis and cannot tolerate ganciclovir/valganciclovir's myelosuppression.

Alternative #5: Trifluridine (Viroptic) — For Herpetic Keratitis Instead of Zirgan

If you need the ganciclovir ophthalmic gel (Zirgan) for herpes simplex keratitis and cannot find it, trifluridine (Viroptic) eye drops are a well-established alternative. Trifluridine is available as both a brand and generic, and unlike Zirgan, generic versions are widely stocked at retail pharmacies. The dosing schedule is slightly more frequent than Zirgan.

Best for: Adults with acute herpetic keratitis (dendritic ulcers) who cannot access Zirgan. Generic trifluridine is typically more affordable and accessible.

Comparison Summary

Valganciclovir: Oral, widely available, first-line alternative for outpatient CMV management

Foscarnet: IV, for resistant CMV; significant kidney toxicity

Cidofovir: IV, weekly dosing, second-line; nephrotoxic

Letermovir: Oral/IV, stem cell transplant prophylaxis only; well tolerated

Trifluridine: Ophthalmic drops, alternative to Zirgan for herpetic keratitis

What to Tell Your Doctor

If you cannot fill your ganciclovir prescription, contact your prescribing provider as soon as possible. Explain that the medication is not available at your pharmacy and ask which alternative they recommend based on your clinical situation. Do not stop or delay treatment without medical guidance — delays in treating CMV retinitis or preventing CMV after transplant can have serious consequences.

You may also want to try medfinder — a service that calls pharmacies near you to check which ones have ganciclovir in stock before you assume it's unavailable in your area.